Robotic partial nephrectomy for renal tumor: The pentafecta outcomes of a single surgeon experience

• Published in: Asian journal of surgery 2023-09, Vol.46 (9), p.3587-3592
• Main Authors: Wang, Bo-Ren, Ou, Yen-Chuan, Huang, Li-Hua, Lu, Chin-Heng, Weng, Wei-Chun, Yang, Cheng-Kuang, Hsu, Chao-Yu, Lin, Yi-Sheng, Chang, Yu-Kang, Tung, Min-Che
• Format: Article
• Language: English
• Subjects: Nephrectomy; Renal cell cancer; Robot- surgery
• ISSN: 1015-9584
• DOI: 10.1016/j.asjsur.2023.05.140

This study investigated the oncological and functional surgical outcomes for patients with renal tumor who underwent robot-assisted partial nephrectomy (PN) by a single surgeon in Taiwan from 2006 to 2019. This retrospective study assessed patients who underwent robot-assisted PN for renal tumor. Patient data were analyzed for age, sex, body mass index, operative time and total ischemic time, surgical margin (positive/negative), and surgical complications. To evaluate functional and oncological outcomes, achievement of trifecta, and pentafecta criteria was used. Trifecta criteria were defined as a negative surgical margin, no postoperative complications, warm ischemia time 90% preservation of estimated glomerular filtration rate (eGFR) preservation, and no stage progression of chronic kidney disease at 1-year follow-up. Of 101 patients who received robot-assisted PN, the most common type of renal tumor was clear cell renal cell carcinoma (RCC) (38%), followed by angiomyolipoma (26%). Patient characteristics were mean age 54.59 ± 13.8 years; mean RENAL Nephrometry score 6.63 ± 2.16; mean operative time 102.34 ± 50.06 min; and warm ischemia time 20.01 ± 14.12 min. The mean eGFR was 104.43 ± 31.73 mL/min/1.73 m2 preoperatively and 89.39 ± 32.3 mL/min/1.73 m2 postoperatively. Pathologic evaluation showed malignant tumors in 57 patients, among whom achievement of trifecta criteria occurred for 39 (68.42%) and pentafecta criteria for 18 (31.57%). Operation time was the only predictor for pentafecta achievement. Robotic PN is a safe and effective approach for patients with renal tumor that can preserve most renal function and achieve oncological control. Pentafecta criteria can be used to more clearly define the surgical outcome of RAPN.